Tempus AI and Pathos AI Sign Neurology Data Deal Worth Up to $55 Million

Tempus will seek to license Pathos 500,000 de-identified records over five years; Bristol Myers Squibb will get Foundry access and three-year exclusive rights to support its neuroscience development programs.

Leave a Reply

Your email address will not be published. Required fields are marked *

UP NEXT

Related Tags

Loading RSS Feed

You May Like

Subscribe To Our Newsletter

Metus in ac vivamus dui id purus in risus. Nunc fringilla donec amet pulvinar vivamus suscipit. Augue porttitor eu sed proin tortor bibendum facilisis felis. Nunc egestas tellus nisl tempor aliquet malesuada ali eu sed proin tortor bibendum facilisis felis
Stay Updated by our Monthly / Weekly News Update. Zero Spamming. Terms & Condition Applied